Torgerson Lance's Form 4 filing
Civeo CorpCVEO · filed Oct 26, 2021
- Accession no.
- 0000899243-21-041626
- Filed
- Oct 26, 2021, 8:10 PM ET
- Trade date
- Oct 22-26, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions. Open-market sales total $392.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Torgerson LanceCIK 0001735901 | 10% Owner |
| Torgerson TammyCIK 0001736750 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 22, 2021 | Common Stock | SSaleDisposed | −5,106 | $22.71F1 | −$115,957.26 | 1,534,225 | Indirect | |
| Oct 22, 2021 | Common Stock | SSaleDisposed | −757 | $22.71F1 | −$17,191.47 | 462,590 | Indirect | |
| Oct 25, 2021 | Common Stock | SSaleDisposed | −4,942 | $22.54F3 | −$111,392.68 | 1,529,283 | Indirect | |
| Oct 25, 2021 | Common Stock | SSaleDisposed | −732 | $22.54F3 | −$16,499.28 | 461,858 | Indirect | |
| Oct 26, 2021 | Common Stock | SSaleDisposed | −5,040 | $22.68F4 | −$114,307.2 | 1,524,243 | Indirect | |
| Oct 26, 2021 | Common Stock | SSaleDisposed | −747 | $22.68F4 | −$16,941.96 | 461,111 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The shares were sold in multiple trades pursuant to a 10b5-1 plan at prices ranging from $22.60 to $22.92. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 2 transactions in Table I.
- F3
The shares were sold in multiple trades pursuant to a 10b5-1 plan at prices ranging from $22.30 to $22.77. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 2 transactions in Table I.
- F4
The shares were sold in multiple trades pursuant to a 10b5-1 plan at prices ranging from $22.60 to $23.10. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 2 transactions in Table I.